Summary
Desacetyl-cefotaxime, the main metabolite of cefotaxime, possesses a broad antibacterial spectrum. Its activity is lower than that of cefotaxime, but significantly surpasses that of cefazolin against gram-negative bacteria. The β-lactamase stability of desacetyl-cefotaxime is higher than that of the parent compound. This β-lactamase stability might be responsible for the synergistic effects of cefotaxime and desacetyl-cefotaxime occasionally seen inin vitro combination studies.
Zusammenfassung
Desacetyl-Cefotaxim, der Hauptmetabolit von Cefotaxim, besitzt ein breites Wirkungsspektrum. In seiner antibakteriellen Aktivität ist es dem Cefotaxim zwar unterlegen, übertrifft aber Cefazolin bei den gramnegativen Erregern deutlich. Die β-Laktamasestabilität von Desacetyl-Cefotaxim ist noch höher als die der Ausgangssubstanz. Diese β-Laktamasestabilität ist möglicherweise der Grund für den inin vitro Kombinationsversuchen gelegentlich nachweisbaren synergistischen Effekt von Cefotaxim und Desacetyl-Cefotaxim.
Similar content being viewed by others
Literature
Schrinner, E., Limbert, M., Penasse, L., Lutz, A. Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro andin vivo). J. Antimicrob. Chemother. 6 Suppl. A (1980) 25–30.
Neu, H. C., Aswapokee, N., Aswapokee, P., Fu, K. P. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Antimicrob. Agents Chemother. 15 (1979) 273–281.
Fu, K. P., Neu, H. C. Beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob. Agents Chemother. 14 (1978) 322–326.
Young, P. W., Husson, J. M., Bruch, K., Blomer, R. J., Savopoulos, C. The evaluation of efficacy and safety of cefotaxime: a review of 2,500 cases. J. Antimicrob. Chemother. 6 Suppl. A (1980) 293–300.
Shah, P. M., Helm, E. B., Stille, W. Management of severe systemic infections caused by multiple resistant organisms. J. Antimicrob. Chemother. 6 Suppl. A (1980) 269–272.
Chamberlain, J., Coombes, J. D., Dell, D., Fromson, J. H., Ings, R. J., Macdonald, C. M., McEwen, J. Metabolism of cefotaxime in animals and man. J. Antimicrob. Chemother. 6 Suppl. A (1980) 69–78.
Reeves, D. S., White, L. O., Holt, H. A., Bahari, D., Bywater, M. J., Bax, R. P. Human metabolism of cefotaxime. J. Antimicrob. Chemother. 6 Suppl. A (1980) 93–111.
Berenbaum, M. C. A method for testing for synergy with any number of agents. J. Infect. Dis. 137 (1978) 122–130.
Norden, C. W., Wentzel, H., Keleti, E. Comparison of techniques for measurement ofin vitro antibiotic synergism. J. Infect. Dis. 140 (1979) 624–633.
O'Callaghan, C. H., Muggelton, P. W., Ross, G. W.: Effects of β-lactamase from gram-negative organisms on cephalosporins and penicillins. Antimicrob. Agents Chemother. (1968) 57–63.
Wise, R., Wills, P. J., Andrews, J. M., Bedford, K. A. Activity of the cefotaxime (HR 756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins. Antimicrob. Agents Chemother. 17 (1980) 84–86.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Limbert, M., Seibert, G. & Schrinner, E. The cooperation of cefotaxime and desacetyl-cefotaxime with respect to antibacterial activity and β-lactamase stability. Infection 10, 97–100 (1982). https://doi.org/10.1007/BF01816732
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01816732